By Beth Winegarner ( June 3, 2015, 8:43 PM EDT) -- District courts' patent claim constructions aren't owed deference under the U.S. Supreme Court's Teva ruling when they aren't based in factual findings, the Federal Circuit ruled Wednesday, reversing a finding that Actavis Inc.'s generic version of inflammatory bowel disease treatment Lialda infringed a Shire Development LLC patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.